'Our advice has not changed': B.C. still providing 2nd AstraZeneca doses after NACI update
British Columbia is not changing its approach to administering second doses of AstraZeneca vaccine in light of updated recommendations from Canada's immunization advisory committee, health officials said Thursday.
The latest national guidance recommends those who received the viral vector vaccine for their first dose get an mRNA vaccine for their second, citing growing evidence that a mix-and-match approach for AstraZeneca recipients provides superior protection.
Despite those findings, provincial health officer Dr. Bonnie Henry said the B.C. government remains confident that two doses of viral vector vaccine adequately protect against COVID-19.
"Here in B.C., our advice has not changed," Henry said. "We can be very reassured that two doses of whatever vaccine you receive are safe and effective."
Henry's response echoed the message coming from the National Advisory Committee on Immunization earlier in the day, which said Canadians who have already received two doses of AstraZeneca can "rest assured" that they are well protected.
B.C. health officials pointed to the "real-world" evidence gathered locally as well as in the U.K., where two doses of AstraZeneca were recently found to be 85 to 90 per cent effective against symptomatic COVID-19.
Henry also noted the data suggesting there's increased effectiveness associated with mixing vaccines remains preliminary.
"It's important to remember that this is new information, that we are continuing to learn as we use more of these vaccines around the world and as more studies are done," the provincial health officer said.
"Mixing an mRNA after a dose of AstraZeneca may give some boost to the immune system, but we don't know whether that translates into (being) better protected or not. We don't know that definitively, and we may not know that for some time."
British Columbia's approach remains that people who received the AstraZeneca vaccine are free to choose whether they want another viral vector dose or would prefer a shot of Pfizer-BioNTech or Moderna.
NACI's guidance recommends that people who received an mRNA vaccine first get another for their booster, but that either of the two will do.
What's important is for the public to get fully protected by receiving a second dose, Henry said, and she encouraged people to do so "as soon as it is available to you."
While announcing their updated recommendations Thursday, NACI officials also cited the very rare risk of blood clots associated with the AstraZeneca vaccine. As of May 31, three people in B.C. had developed vaccine-induced immune thrombotic thrombocytopenic, or VITT.
According to the B.C. Centre for Disease Control, the risk of serious blood clots after receiving a first shot of AstraZeneca is about one in 100,000. That risk is said to decrease to one in 600,000 for second doses.
CTVNews.ca Top Stories
NDP calls out Conservatives for effort to squash pharmacare legislation
The federal New Democrats are calling out Conservative Leader Pierre Poilievre and his party for trying to block the bill that could pave the way for millions of Canadians to access birth control and diabetes coverage.
Winnipeg man admits to killing four women, argues he's not criminally responsible
Defence lawyers of Jeremy Skibicki have admitted in court the accused killed four Indigenous women, but argues he is not criminally responsible for the deaths by way of mental disorder – this latest development has triggered a judge-alone trial rather than a jury trial.
Mediterranean staple may lower your risk of death from dementia, study finds
A daily spoonful of olive oil could lower your risk of dying from dementia, according to a new study by Harvard scientists.
An El Nino-less summer is coming. Here's what that could mean for Canada
As Canadians brace themselves for summer temperatures, forecasters say a weakening El Nino cycle doesn’t mean relief from the heat.
Stamp prices rise for the third time in five years amid financial woes for Canada Post
Canada Post is increasing stamp prices for the third time since 2019, a move the Crown corporation says is a "reality" of its sales-based revenue structure.
For the first time, researchers have identified a genetic form of late-in-life Alzheimer's disease
For the first time, researchers have identified a genetic form of late-in-life Alzheimer’s disease — in people who inherit two copies of a worrisome gene.
B.C. court date set for 3 accused of murdering Sikh activist Hardeep Singh Nijjar
Three suspects accused of murdering British Columbia Sikh activist Hardeep Singh Nijjar last year are scheduled to appear in court in Surrey on Tuesday.
Ontario MPP asked again to leave Ontario legislature over keffiyeh, Speaker loosens ban
An Ontario MPP was asked again to leave the Ontario legislature on Monday for wearing a keffiyeh, a garment that was banned by the Speaker last month due to its political symbolism.
WATCH Avian flu: Risk to humans grows as outbreaks spread, warns expert
H5N1 or avian flu is decimating wildlife around the world and is now spreading among cattle in the United States, sparking concerns about 'pandemic potential' for humans. Now a health expert is urging Canada to scale up surveillance north of the border.